Translating Discoveries into Medicine: Psychiatric Drug Development in 2011
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Link
http://www.nature.com/articles/npp2011106.pdf
Reference10 articles.
1. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature 473: 221–225.
2. Cohen AF (2010). Developing drug prototypes: pharmacology replaces safety and tolerability? Nat Rev Drug Discov 9: 856–865.
3. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K et al (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167: 748–751.
4. Insel TR (2007). From animal models to model animals. Biol Psychiatry 62: 1337–1339.
5. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y et al (2010). A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143: 527–539.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Experimental Medicine Approaches in Early-Phase CNS Drug Development;Advances in Neurobiology;2023
2. Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial;Journal of Neural Transmission;2022-11-19
3. Multiparametric Assays for Accelerating Early Drug Discovery;Trends in Pharmacological Sciences;2020-05
4. A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia;Nature Medicine;2020-03-30
5. Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial;Contemporary Clinical Trials Communications;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3